Braavos Investment Advisers

PQShield Ltd is a company based in Oxford, United Kingdom, that specializes in providing quantum-secure cryptographic solutions to enhance cybersecurity in the face of emerging quantum computing threats. Founded in 2018, PQShield develops a range of products including PQSoC, a toolkit for post-quantum system on chip crypto co-processors; PQSDK, which integrates post-quantum primitives with the OpenSSL API; and PQE2E, a software development toolkit for secure data messaging using post-quantum algorithms. The company focuses on securing technology infrastructures across various domains, offering both ready-made and customized intellectual property to facilitate the transition from traditional cryptographic standards, such as RSA and Elliptic Curve, to quantum-safe alternatives. Through its innovations, PQShield aims to safeguard sensitive data and communications, contributing to the advancement of robust digital security in an evolving technological landscape.

OxCCU is a technology developer focused on facilitating a circular economy for fuels, chemicals, and plastics. It achieves this by innovating renewable energy solutions that convert atmospheric carbon dioxide into valuable products such as fuels, chemicals, and biodegradable plastics using hydrogen derived from water and renewable electricity.

Oxford Ionics is a quantum computing startup focused on developing high-performance quantum computers through the use of trapped-ion technology. The company combines advanced qubit designs with a noiseless electronic control system, allowing for accurate and reliable manipulation of qubits. This technology enables the parallel control of interconnected qubit registers, ensuring performance is not compromised. By employing standard semiconductor fabrication methods, Oxford Ionics aims to create scalable quantum chips that enhance computational capabilities for complex problem-solving. The company's innovations position it to significantly advance the quantum computing market, providing clients with dependable solutions for high-performance applications.

Osler Diagnostics is a UK-based company focused on providing accessible and accurate health diagnostics. Founded in 2017 as a spin-off from the University of Oxford, the company has leveraged extensive research in portable diagnostic technologies, originally stemming from the development of the blood glucose sensor. Its flagship product, the Osler Origin, is a portable laboratory capable of delivering lab-quality diagnostics anytime and anywhere, enabling individuals to conduct tests for a variety of health biomarkers using just a drop of blood. This innovative approach aims to decentralize healthcare, making it easier for users to monitor their health and make informed decisions, ultimately supporting healthier and longer lives. Osler Diagnostics is headquartered in Oxford, UK, and aims to serve all major healthcare settings globally.

CHARM Therapeutics is a biotechnology company focused on delivering innovative medicines by leveraging advanced 3D deep learning and drug discovery technologies. Its platform is designed to address challenging disease targets that are typically considered undruggable, thereby enhancing treatment options for patients. By utilizing cutting-edge methodologies, CHARM Therapeutics aims to develop therapeutics with transformational efficacy, ultimately assisting healthcare professionals in improving patient outcomes.

First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

SpyBiotech Limited is a biotechnology company based in Oxford, United Kingdom, founded in 2017. The company specializes in the development of molecular superglue technology, which is utilized to create next-generation vaccines. This proprietary platform allows for the bonding of antigens to viruses and other particles, facilitating the rapid development of vaccines targeting a variety of diseases. By employing this innovative approach, SpyBiotech aims to enhance vaccine efficacy and reduce the time required for development, thereby providing medical institutions and research centers with advanced solutions for combating bacterial infections and other health challenges.

Stockbit is an investment community based in Indonesia that facilitates real-time sharing of stock-related ideas, news, and financial information. The platform allows users to create profiles and follow specific stocks or favorite investors, providing access to valuable insights and discussions. It features monitoring tools for stock price charts and comprehensive financial data, enabling users to analyze individual stocks and engage in informed discussions. Stockbit is dedicated to enhancing the investment experience within the Indonesian market, empowering both individual investors and traders to make well-informed decisions.